Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasisMélanie Tichet, Sophie Tartare‐Deckert|Nature Communications|2015Cited by 199
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophagesMélanie Tichet, Douglas Hanahan|Immunity|2023Cited by 127